WAKAMOTO PHARMACEUTICAL CO.,LTD.
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
4512 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町二丁目２番２号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Wakamoto Pharmaceutical Co., Ltd. is a research-driven pharmaceutical company engaged in the development, manufacturing, and sale of prescription (ethical) and over-the-counter (OTC) medicines. The company specializes in two primary therapeutic areas: gastroenterology and ophthalmology. Its product portfolio includes the well-known gastrointestinal drug "Strong Wakamoto," which utilizes a proprietary microorganism to produce digestive enzymes, and a range of ophthalmic solutions for treating eye disorders. Wakamoto Pharmaceutical focuses its research and development efforts on creating medications and medical equipment to address the health challenges of an aging society.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-27 10:03 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 24.7 KB | ||
| 2025-06-20 08:53 |
Governance Information
内部統制報告書－第130期(2024/04/01－2025/03/31)
|
Japanese | 21.5 KB | ||
| 2025-06-20 08:51 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2025-06-20 08:48 |
Annual Report
有価証券報告書－第130期(2024/04/01－2025/03/31)
|
Japanese | 1014.1 KB | ||
| 2025-02-06 08:28 |
Major Shareholding Notification
臨時報告書
|
Japanese | 19.3 KB | ||
| 2024-11-13 01:51 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | ||
| 2024-11-13 01:46 |
Interim Report
半期報告書－第130期(2024/04/01－2025/03/31)
|
Japanese | 183.5 KB | ||
| 2024-07-02 05:00 |
Regulatory News Service
臨時報告書
|
Japanese | 33.6 KB | ||
| 2024-06-28 08:24 |
Regulatory News Service
内部統制報告書－第129期(2023/04/01－2024/03/31)
|
Japanese | 21.7 KB | ||
| 2024-06-28 08:21 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | ||
| 2024-06-28 08:19 |
Annual Report
有価証券報告書－第129期(2023/04/01－2024/03/31)
|
Japanese | 1007.9 KB | ||
| 2024-02-14 01:17 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2024-02-14 01:17 |
Quarterly Report
四半期報告書－第129期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 155.8 KB | ||
| 2023-11-13 01:54 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2023-11-13 01:53 |
Quarterly Report
四半期報告書－第129期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 187.2 KB |
Automate Your Workflow. Get a real-time feed of all WAKAMOTO PHARMACEUTICAL CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for WAKAMOTO PHARMACEUTICAL CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
